AIM : To study the correlation of HBsAg quantification levels with HBV DNA in patients with chronic hepatitis B infection.Also to study the role of qHbsAg levels in predicting the response to antiviral therapy in chronic hepatitis B infection. MATERIALS AND METHODS : one year prospective study conducted between January 2014-2015 at department of digestive health and diseases, kilpauk medical college,chennai. All patients of chronic hepatitis B infection were included in the study. Baseline liverfunction tests, HbsAg quantification and HBVDNA levels were done. In treatment group the above values are repeated every 12 weeks for 36 weeks. RESULTS : Total of 160 patients were included and among them 24 were in treatment group. The results a...
(1) Background: As specialparameters in predicting significant hepatitis activity of hepatitis B e a...
Despite universal vaccination, chronic hepatitis B (CHB) continues to be a major health burden world...
Hepatitis B virus (HBV) is the leading cause of viral hepatitis, as currently over 2 billion people ...
Chronic HBV infection is prevalent in Indian population with prevalence rate of 2-4% . It is wellk...
INTRODUCTION : There are approximately 400 million hepatitis B virus (HBV) carriers in the world. ...
Background: Methods used to diagnose and monitor chronic hepatitis B (CHB) by quantitation of hepati...
Background: Methods used to diagnose and monitor chronic hepatitis B (CHB) by quantitation of hepati...
The prevalence of hepatitis B infection in Indonesia is still alarming, while its therapies cannot e...
Background: In recent times, the hepatitis B virus surface antigen (HBsAg) level, a cheaper marker c...
In the past 10years, there has been a lot of enthusiasm surrounding the use of serum hepatitis B sur...
Background/Aims: Fluctuations in hepatitis B virus (HBV) DNA and alanine transaminase (ALT) levels c...
Quantitative HBsAg had been suggested to be helpful in management of HBV, but assays were cumbersome...
To determine the role of quantitative HBsAg levels in follow up of chronic HBV treatment and investi...
Background: Serum HBV DNA is a useful and reliable marker to diagnose and monitor CHB on treatment. ...
Background: Methods used to diagnose and monitor chronic hepatitis B (CHB) by quantitation of hepati...
(1) Background: As specialparameters in predicting significant hepatitis activity of hepatitis B e a...
Despite universal vaccination, chronic hepatitis B (CHB) continues to be a major health burden world...
Hepatitis B virus (HBV) is the leading cause of viral hepatitis, as currently over 2 billion people ...
Chronic HBV infection is prevalent in Indian population with prevalence rate of 2-4% . It is wellk...
INTRODUCTION : There are approximately 400 million hepatitis B virus (HBV) carriers in the world. ...
Background: Methods used to diagnose and monitor chronic hepatitis B (CHB) by quantitation of hepati...
Background: Methods used to diagnose and monitor chronic hepatitis B (CHB) by quantitation of hepati...
The prevalence of hepatitis B infection in Indonesia is still alarming, while its therapies cannot e...
Background: In recent times, the hepatitis B virus surface antigen (HBsAg) level, a cheaper marker c...
In the past 10years, there has been a lot of enthusiasm surrounding the use of serum hepatitis B sur...
Background/Aims: Fluctuations in hepatitis B virus (HBV) DNA and alanine transaminase (ALT) levels c...
Quantitative HBsAg had been suggested to be helpful in management of HBV, but assays were cumbersome...
To determine the role of quantitative HBsAg levels in follow up of chronic HBV treatment and investi...
Background: Serum HBV DNA is a useful and reliable marker to diagnose and monitor CHB on treatment. ...
Background: Methods used to diagnose and monitor chronic hepatitis B (CHB) by quantitation of hepati...
(1) Background: As specialparameters in predicting significant hepatitis activity of hepatitis B e a...
Despite universal vaccination, chronic hepatitis B (CHB) continues to be a major health burden world...
Hepatitis B virus (HBV) is the leading cause of viral hepatitis, as currently over 2 billion people ...